BACKGROUND: Data on efficacy of artemisinin-based combination therapy (ACT) to treat Plasmodium falciparum during pregnancy in sub-Saharan Africa is scarce. A recent open label, randomized controlled trial in Mbarara, Uganda demonstrated that artemether-lumefantrine (AL) is not inferior to quinine to treat uncomplicated malaria in pregnancy. Haemozoin can persist in the placenta following clearance of parasites, however there is no data whether ACT can influence the amount of haemozoin or the dynamics of haemozoin clearance. METHODS:Women attending antenatal clinics with weekly screening and positive blood smears by microscopy were eligible to participate in the trial and were followed to delivery. Placental haemozoin deposition and inflammation were assessed by histology. To determine whether AL was associated with increased haemozoin clearance, population haemozoin clearance curves were calculated based on the longitudinal data. RESULTS: Of 152 women enrolled in each arm, there were 97 and 98 placental biopsies obtained in the AL and quinine arms, respectively. AL was associated with decreased rates of moderate to high grade haemozoin deposition (13.3% versus 25.8%), which remained significant after correcting for gravidity, time of infection, re-infection, and parasitaemia. The amount of haemozoin proportionately decreased with the duration of time between treatment and delivery and this decline was greater in the AL arm. Haemozoin was not detected in one third of biopsies and the prevalence of inflammation was low, reflecting the efficacy of antenatal care with early detection and prompt treatment of malaria. CONCLUSIONS:Placental haemozoin deposition was decreased in the AL arm demonstrating a relationship between pharmacological properties of drug to treat antenatal malaria and placental pathology at delivery. Histology may be considered an informative outcome for clinical trials to evaluate malaria control in pregnancy. REGISTRY: http://clinicaltrials.gov/ct2/show/NCT00495508.
RCT Entities:
BACKGROUND: Data on efficacy of artemisinin-based combination therapy (ACT) to treat Plasmodium falciparum during pregnancy in sub-Saharan Africa is scarce. A recent open label, randomized controlled trial in Mbarara, Uganda demonstrated that artemether-lumefantrine (AL) is not inferior to quinine to treat uncomplicated malaria in pregnancy. Haemozoin can persist in the placenta following clearance of parasites, however there is no data whether ACT can influence the amount of haemozoin or the dynamics of haemozoin clearance. METHODS:Women attending antenatal clinics with weekly screening and positive blood smears by microscopy were eligible to participate in the trial and were followed to delivery. Placental haemozoin deposition and inflammation were assessed by histology. To determine whether AL was associated with increased haemozoin clearance, population haemozoin clearance curves were calculated based on the longitudinal data. RESULTS: Of 152 women enrolled in each arm, there were 97 and 98 placental biopsies obtained in the AL and quinine arms, respectively. AL was associated with decreased rates of moderate to high grade haemozoin deposition (13.3% versus 25.8%), which remained significant after correcting for gravidity, time of infection, re-infection, and parasitaemia. The amount of haemozoin proportionately decreased with the duration of time between treatment and delivery and this decline was greater in the AL arm. Haemozoin was not detected in one third of biopsies and the prevalence of inflammation was low, reflecting the efficacy of antenatal care with early detection and prompt treatment of malaria. CONCLUSIONS: Placental haemozoin deposition was decreased in the AL arm demonstrating a relationship between pharmacological properties of drug to treat antenatalmalaria and placental pathology at delivery. Histology may be considered an informative outcome for clinical trials to evaluate malaria control in pregnancy. REGISTRY: http://clinicaltrials.gov/ct2/show/NCT00495508.
Authors: Meghna Desai; Feiko O ter Kuile; François Nosten; Rose McGready; Kwame Asamoa; Bernard Brabin; Robert D Newman Journal: Lancet Infect Dis Date: 2007-02 Impact factor: 25.071
Authors: Francis Bajunirwe; Iyesatta Massaquoi; Stephen Asiimwe; Moses R Kamya; Eric J Arts; Christopher C Whalen Journal: Afr Health Sci Date: 2004-12 Impact factor: 0.927
Authors: Sharon E Cox; Trine Staalsoe; Paul Arthur; Judith N Bulmer; Harry Tagbor; Lars Hviid; Chris Frost; Eleanor M Riley; Betty R Kirkwood Journal: Trop Med Int Health Date: 2005-12 Impact factor: 2.622
Authors: George K K Lau; Teerha Piratvisuth; Kang Xian Luo; Patrick Marcellin; Satawat Thongsawat; Graham Cooksley; Edward Gane; Michael W Fried; Wan Cheng Chow; Seung Woon Paik; Wen Yu Chang; Thomas Berg; Robert Flisiak; Philip McCloud; Nigel Pluck Journal: N Engl J Med Date: 2005-06-30 Impact factor: 91.245
Authors: Ayôla A Adegnika; Lutz Ph Breitling; Selidji T Agnandji; Sanders K Chai; Daniela Schütte; Sunny Oyakhirome; Norbert G Schwarz; Martin P Grobusch; Michel A Missinou; Michael Ramharter; Saadou Issifou; Peter G Kremsner Journal: Am J Trop Med Hyg Date: 2005-08 Impact factor: 2.345
Authors: Ric N Price; Grant Dorsey; Elizabeth A Ashley; Karen I Barnes; J Kevin Baird; Umberto d'Alessandro; Philippe J Guerin; Miriam K Laufer; Inbarani Naidoo; François Nosten; Piero Olliaro; Christopher V Plowe; Pascal Ringwald; Carol H Sibley; Kasia Stepniewska; Nicholas J White Journal: Malar J Date: 2007-09-06 Impact factor: 2.979
Authors: Renée J Burger; Anna M van Eijk; Milena Bussink; Jenny Hill; Feiko O Ter Kuile Journal: Open Forum Infect Dis Date: 2015-11-12 Impact factor: 3.835
Authors: Chonge Kitojo; Frank Chacky; Emmanuel S Kigadye; Joseph P Mugasa; Abdallah Lusasi; Ally Mohamed; Patrick Walker; Erik J Reaves; Julie R Gutman; Deus S Ishengoma Journal: Malar J Date: 2020-11-30 Impact factor: 2.979
Authors: Mary K Muhindo; Abel Kakuru; Paul Natureeba; Patricia Awori; Peter Olwoch; John Ategeka; Patience Nayebare; Tamara D Clark; Atis Muehlenbachs; Michelle Roh; Betty Mpeka; Bryan Greenhouse; Diane V Havlir; Moses R Kamya; Grant Dorsey; Prasanna Jagannathan Journal: Malar J Date: 2016-08-26 Impact factor: 2.979
Authors: Makoto Saito; Rashid Mansoor; Kalynn Kennon; Anupkumar R Anvikar; Elizabeth A Ashley; Daniel Chandramohan; Lauren M Cohee; Umberto D'Alessandro; Blaise Genton; Mary Ellen Gilder; Elizabeth Juma; Linda Kalilani-Phiri; Irene Kuepfer; Miriam K Laufer; Khin Maung Lwin; Steven R Meshnick; Dominic Mosha; Atis Muehlenbachs; Victor Mwapasa; Norah Mwebaza; Michael Nambozi; Jean-Louis A Ndiaye; François Nosten; Myaing Nyunt; Bernhards Ogutu; Sunil Parikh; Moo Kho Paw; Aung Pyae Phyo; Mupawjay Pimanpanarak; Patrice Piola; Marcus J Rijken; Kanlaya Sriprawat; Harry K Tagbor; Joel Tarning; Halidou Tinto; Innocent Valéa; Neena Valecha; Nicholas J White; Jacher Wiladphaingern; Kasia Stepniewska; Rose McGready; Philippe J Guérin Journal: BMC Med Date: 2020-06-02 Impact factor: 8.775